EastPharma : EP DEVA H1 2018 IRCall

USD / TRY Exchange Rate

The period end USD/TRY exchange rate increased by 20.9%; 3.7719 as of 31 December 2017; 4.5607 as of 30 June 2018.

The average USD/TRY exchange rate strengthened by 12.4%; 3.6356 for H1 2017;4.0860 for H1 2018.

Revenues in H1 2018 reached to US$ 132.1mn (TRY 539.6mn) vs US$ 113.8mn (TRY 413.6mn) in H1 2017.

• 16.1% year-on-year increase in US$

• 30.5% year-on-year increase in TRY

Revenues : ($. mn)

2016

2017

H1'17

H1'18

Revenues Breakdown:

Human PharmaVeterinary GoodsOther

Domestic SalesExport Sales

6.13%

1.33%

7.7%

92.54%

92.3%

EastPharma Financial Performance (IFRS)-30.06.2018

Gross Profit : ($. mn)

• 25.9% year-on-year increase